Keyphrases
Co-treatment
70%
Preclinical Efficacy
69%
AML Cells
54%
EVI1
50%
Menin Inhibitors
46%
MLL1
46%
Epigenetics
46%
Myeloid Malignancies
46%
B-cell Lymphoma 2 (Bcl-2)
32%
Overexpression
30%
Nucleophosmin 1 (NPM1)
30%
Venetoclax
26%
Effective Therapy
25%
Acute Myeloid Leukemia Cells
25%
FLT3 mutation
25%
Interdependency
25%
Novel Agents
23%
Chimera
23%
Cellular Models
23%
Human Keratinocytes (HaCaT)
23%
Acute Myeloid Leukemia
23%
Proteolysis
23%
Systemic Aging
23%
3q26
23%
Epigenetic Mechanisms
23%
Mutator Mouse
23%
Dysregulation
23%
Richter Transformation
23%
MLL Rearrangement
23%
Diffuse Large B-cell Lymphoma (DLBCL)
23%
Epstein-Barr Virus Infections
23%
NPM1 mutation
23%
Genome-wide DNA Methylation
23%
Protein Translation
23%
RUNX1 mutation
23%
Epstein-Barr Virus
23%
Inherited Platelet Disorders
23%
Secondary Acute Myeloid Leukemia (sAML)
23%
Myeloproliferative Neoplasms
23%
CDK7
23%
FLT3 Inhibitor
23%
BRG1
23%
Lethality
21%
BET Inhibitor
19%
C-Myc
19%
Omacetaxine
19%
Stem Progenitor Cells
18%
Runt-related Transcription Factor 1 (RUNX1)
17%
Patient-derived
17%
Bromodomain-containing Protein 4 (BRD4)
12%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Methionine
69%
NPM1
56%
Enhancer Region
52%
Epigenetics
48%
Gene Expression
40%
Oncogene C Myc
39%
BRD4
37%
Progenitor Cell
36%
CRISPR
33%
Immunity
31%
RUNX1
28%
LSD1
25%
Ruxolitinib
25%
Stem Cell
24%
B Cell
24%
Messenger RNA
23%
Mitochondrial Disorder
23%
GFI1
23%
Platelet
23%
Proteolysis
23%
DNA Methylation
23%
Programmed Cell Death
23%
Translation (Protein Synthesis)
23%
IRF4
23%
Mitochondrial DNA
23%
Keratinocyte
23%
Epigenetic Mechanism
23%
Epstein Barr Virus
23%
Interferon Type I
23%
RNA Sequencing
18%
Lymphoid Enhancer-Binding Factor 1
15%
Mitochondrion
15%
TCF7L2
15%
Polymerase
15%
N-Myc
14%
SMARCA2
13%
SMARCA4
13%
MCL1
11%
Discrimination Learning
11%
TCF4
11%
Ibrutinib
11%
Drug Sensitivity
11%
Gene Mutation
11%
Protein Expression
11%
Growth Inhibition
11%
Protein Tertiary Structure
9%
Genetics
9%
Transcription Factor
9%
MDS1 and EVI1 Complex Locus Protein
9%
Medicine and Dentistry
Acute Myelogenous Leukemia
76%
Myeloid Malignancy
46%
NPM1
46%
Methionine
31%
Gene Linkage
23%
Interferon Type I
23%
Oral Cancer
23%
Cellular Model
23%
Mutagenic Agent
23%
Mitochondrial DNA
23%
Accelerated Aging
23%
Platelet Disorder
23%
Virus
23%
Therapeutic Agent
23%
Immunity
13%
Polymerase
11%
Mitochondrion
11%
Mitochondrial Disorder
11%
Cancer
10%
Progenitor Cell
8%
Xenograft
8%
RNA Sequencing
8%
Volasertib
7%
Lethality
6%
Monotherapy
6%
In Vitro
5%
Ecotropic Viral Integration Site-1
5%
Oxidative Stress
5%
Disease
5%
Zinc Finger Protein
5%
Disorders of Mitochondrial Functions
5%
Transcription Factor
5%
Prothrombin
5%
Cytokine Response
5%
Innate Immunity
5%
Nuclear Factor
5%
Immunopathology
5%
Serositis
5%
Diseases
5%
Cardiovascular System
5%
Aerobic Glycolysis
5%
Disease Exacerbation
5%
Clustered Regularly Interspaced Short Palindromic Repeat
5%
